Rotator cuff injuries are a leading cause of shoulder disability among adults.^[@bibr11-2325967119845912]^ Surgical intervention is a common treatment modality that aims to promote tendon-bone healing by reconstituting the native tendinous footprint at its insertion on the humerus and to re-establish normal biomechanical behavior.^[@bibr5-2325967119845912]^ Despite the frequency of performing rotator cuff repair, only a minority of rotator cuff tears require surgical intervention.^[@bibr12-2325967119845912]^ Pharmacological treatments, such as nonsteroidal anti-inflammatory drugs (NSAIDs), and nonpharmacological treatments, such as corticosteroid injections and physical therapy (PT), have been described in the management of rotator cuff tears, with the goal of reducing pain and physical disability and improving function.^[@bibr4-2325967119845912],[@bibr17-2325967119845912],[@bibr28-2325967119845912],[@bibr30-2325967119845912]^

As the cost of health care increases, the industry has shifted to optimizing patient outcomes, reducing readmissions, and reducing expenditures.^[@bibr33-2325967119845912],[@bibr37-2325967119845912],[@bibr42-2325967119845912]^ In 2010, the American Academy of Orthopaedic Surgeons (AAOS) created clinical practice guidelines (CPGs) to optimize the management of rotator cuff tears.^[@bibr2-2325967119845912],[@bibr35-2325967119845912]^ After a rigorous systematic review, the CPGs were synthesized based on current evidence in the available literature. The AAOS provided a consensus agreement that surgery should not be performed for asymptomatic, full-thickness rotator cuff tears. Furthermore, a moderate strength of recommendation was given to not perform routine acromioplasty at the time of index rotator cuff repair, treating non--full thickness rotator cuff tears conservatively with exercise or NSAIDs. An additional finding was that workers' compensation status correlated with less favorable outcomes after rotator cuff repair. The CPGs on rotator cuff tears were based on lower levels of evidence, such as case series or case-control investigations.^[@bibr23-2325967119845912]^

Many randomized controlled trials regarding rotator cuff tears have been published since the publication of the CPGs in 2010. Clinical trials regarding operative versus nonoperative management of rotator cuff tears,^[@bibr18-2325967119845912],[@bibr32-2325967119845912]^ concomitant procedures,^[@bibr1-2325967119845912],[@bibr21-2325967119845912]^ operative techniques,^[@bibr22-2325967119845912],[@bibr38-2325967119845912]^ biological augmentation,^[@bibr9-2325967119845912],[@bibr13-2325967119845912]^ and postoperative rehabilitation protocols^[@bibr20-2325967119845912],[@bibr29-2325967119845912]^ have been performed. The results of these investigations have indicated that rotator cuff repair for full-thickness rotator cuff tears offers improved outcomes in comparison with conservative treatment; however, the difference may not reach clinical importance.^[@bibr18-2325967119845912],[@bibr32-2325967119845912]^ Randomized controlled trials are the highest form of scientific evidence; therefore, the results of these investigations have the potential to alter or guide clinical management.

The purpose of this study was to assess the current practice patterns of full-thickness rotator cuff tears and compare them with practice patterns before the publication of the CPGs and the majority of prospective clinical trials. We hypothesized that the practice patterns of full-thickness rotator cuff tears have changed more than time and more closely align with the CPGs as well as the outcomes of recent clinical trials.

Methods {#section1-2325967119845912}
=======

The present study was a retrospective review of Humana patient data within the PearlDiver patient records database (PearlDiver Inc) from 2010 and 2015. This private-insurer database represents more than 20 million patients in the United States, containing data regarding patient demographics, details regarding hospitalization, diagnoses, procedures, and reimbursement. Comparatively, the Medicare database within PearlDiver includes patients insured by Medicare beneficiaries from 2005 to 2014, totaling approximately 55 million patients. These databases use the International Classification of Diseases--9th Revision, Clinical Modification, and --10th Revision, Clinical Modification (ICD-9-CM and ICD-10-CM, respectively), procedural codes as well as Current Procedural Terminology (CPT) codes. The accessed data represent procedures and diagnoses that were billed to the insurance company by the provider during that period. All information in the PearlDiver database is deidentified and anonymous, and the database allows for longitudinal tracking of patients through Boolean search commands. Because of the anonymity of the database, institutional review board approval was not needed for this investigation.

Two reference groups were created: a repair group of patients with full-thickness rotator cuff tears treated with open or arthroscopic rotator cuff repair (CPT-29827, CPT-23410, CPT-23412, CPT-23420)^[@bibr12-2325967119845912]^ and a nonoperative group of patients diagnosed with full-thickness rotator cuff tears without undergoing rotator cuff repair ([Table 1](#table1-2325967119845912){ref-type="table"}). To correspond with the publication of the CPGs by the AAOS in December 2010, a reference group was formed in the final year before the release of the CPGs (2010) as well as in 2015. A summary of the CPGs is provided in [Table 2](#table2-2325967119845912){ref-type="table"}. Although the CPGs did not offer any recommendations regarding biceps tenodesis, management of the biceps tendon remains an important variable during rotator cuff repair because of its role as an independent anterior shoulder pain generator.^[@bibr8-2325967119845912]^ Therefore, changes in operative management that included concomitant biceps tenodesis were assessed. Several CPGs that have at least moderate evidence, such as workers' compensation status or use of cold therapy postoperatively, could not be accurately discernible from the database; therefore, these variables were not investigated. Distinguishing between symptomatic and asymptomatic rotator cuff tears was unable to be performed in this database. The use of a xenograft could not accurately be discernible from the database, as this may code for superior capsular reconstruction; therefore, it was excluded from analysis. In both the repair and the nonoperative groups, patients who underwent rotator cuff repair before the queried year were excluded. In the nonoperative group, only patients with a diagnosis of a rotator cuff tear who did not undergo repair in the queried year were included.

###### 

Queried ICD-9/10 and CPT/HCPCS Codes*^a^*

![](10.1177_2325967119845912-table1)

                                     ICD-9/10 Code                                                                                                                      CPT/HCPCS Code
  ---------------------------------- ---------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
  Full-thickness rotator cuff tear   727.61, 726.10, 840.3, 840.4, 840.5, 840.6, M75.120, M75.121, M75.122, S46.011A, S46.012A, S46.019A, M75.110, S43.80XA, S43.429A   
  Corticosteroid injection                                                                                                                                              J0702, J0704, J1020, J1030, J1040, J1094, J1100, J1700, J1720, J2650, J2920, J2930, J3300, J3301, J3302, J3303
  Physical therapy                                                                                                                                                      97001, 97002, 97003, 97010, 97014, 97032, 97033, 97035, 97110, 97112, 97140, 97530

*^a^*Because of the vast number of National Drug Codes (NDCs) for nonsteroidal anti-inflammatory drugs, these codes were not provided. The PearlDiver database groups all NDCs for medication classes together. CPT, Current Procedural Terminology; HCPCS, Healthcare Common Procedure Coding System; ICD, International Classification of Diseases.

###### 

Summary of Clinical Practice Guidelines*^a^*

![](10.1177_2325967119845912-table2)

  Guideline                                                                                                                                                      Strength of Recommendation
  -------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------
  Surgery should not be performed for asymptomatic, full-thickness rotator cuff tears                                                                            Consensus
  Patients who have rotator cuff--related symptoms in the absence of a full-thickness tear should be initially treated nonoperatively using exercise or NSAIDs   Moderate
  Workers' compensation status correlates with a less favorable outcome after rotator cuff surgery                                                               Moderate
  Routine acromioplasty is not required at the time of rotator cuff repair                                                                                       Moderate
  Surgeons should not use a non-crosslinked, porcine, small intestine submucosal xenograft to treat patients with rotator cuff tears                             Moderate
  Local cold therapy is beneficial to relieve pain after rotator cuff surgery                                                                                    Consensus
  We cannot recommend for or against exercise programs for patients with rotator cuff tears                                                                      Inconclusive
  We cannot recommend for or against subacromial injections for patients with rotator cuff tears                                                                 Inconclusive
  We cannot recommend for or against the use of NSAIDs for the nonoperative management of rotator cuff tears                                                     Inconclusive

*^a^*From the American Academy of Orthopaedic Surgeons (2010).^[@bibr2-2325967119845912]^ NSAID, nonsteroidal anti-inflammatory drug.

In the repair group, patients who underwent rotator cuff repair because of a full-thickness tear in the queried year and who previously underwent PT, received a corticosteroid injection, or received an NSAID for the full-thickness rotator cuff tear before surgery were identified through administrative claims records. In the nonoperative group, patients who underwent PT, received a corticosteroid injection, or received an NSAID in the same year as the diagnosis of a full-thickness tear without rotator cuff repair were also identified. Only patients with an ICD-9 or ICD-10 diagnosis code of a full-thickness rotator cuff tear in their record were included in this investigation. Corticosteroid injections were identified with large-joint injection codes (CPT-20610, CPT-20611) with the respective corticosteroid Healthcare Common Procedure Coding System (HCPCS) codes. To guarantee that the investigators solely captured shoulder injections, only injections with an ICD-9 or ICD-10 diagnosis code of a full-thickness rotator cuff tear on the day of the injection were included in this investigation. PT codes specific to full-thickness rotator cuff tears were queried as described by Arshi et al.^[@bibr3-2325967119845912]^ Last, NSAIDs were identified by a group of National Drug Codes within the PearlDiver database.

Patients who underwent concomitant acromioplasty (CPT-23130, CPT-29826, CPT-29826-51, CPT-29826-59) or biceps tenodesis (CPT-29828, CPT-23430) with rotator cuff repair were also identified. Patients who underwent magnetic resonance imaging (CPT-73221, CPT-73222, CPT-73223) with the diagnosis of a full-thickness rotator cuff tear before operative management were also identified.

Statistical Analysis {#section2-2325967119845912}
--------------------

Statistical analysis was conducted using Excel (Microsoft). Frequencies and percentages were used to report discrete variables. Chi-square analysis was performed for all categorical variables to calculate odds ratios (ORs) and *P* values. Statistical significance was set at *P* ≤ .05.

Results {#section3-2325967119845912}
=======

In 2010, there were 60,665 diagnoses of full-thickness rotator cuff tears, with 5601 rotator cuff repairs (9.2% of total diagnoses), while in 2015, there were 99,251 diagnoses of full-thickness rotator cuff tears and 9878 rotator cuff repairs (10.0% of total diagnoses) (*P* \< .001) ([Table 3](#table3-2325967119845912){ref-type="table"}). Patient demographics are provided in [Table 4](#table4-2325967119845912){ref-type="table"}.

###### 

Distribution of Rotator Cuff Diagnoses*^a^*
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                       2010 (n = 60,665 Tears)   2015 (n = 99,251 Tears)
  -------------------- ------------------------- -------------------------
  Repair group         5601 (9.2)                9878 (10.0)
  Nonoperative group   55,064 (90.8)             89,373 (90.0)

*^a^*Data are reported as n (%).

###### 

Patient Demographics*^a^*

![](10.1177_2325967119845912-table4)

                 2010          2015                          
  -------------- ------------- --------------- ------------- ---------------
  Male           2675 (47.8)   24,406 (44.3)   3515 (53.2)   38,955 (43.6)
  Female         2926 (52.2)   30,658 (55.7)   3094 (46.8)   50,420 (56.4)
  Age group, y                                               
   \<50          486 (8.7)     7932 (14.4)     429 (6.5)     9467 (10.6)
   50-59         924 (16.5)    8052 (14.6)     1141 (17.3)   12,060 (13.5)
   60-69         2149 (38.4)   14,930 (27.1)   2668 (40.4)   26,016 (29.1)
   70-79         1741 (31.1)   15,973 (29.0)   2074 (31.4)   28,542 (31.9)
   ≥80           301 (5.4)     8177 (14.8)     297 (4.5)     13,286 (14.9)

*^a^*Data are reported as n (%).

Physical Therapy {#section4-2325967119845912}
----------------

In 2010, a total of 679 patients (12.1%) in the repair group and 9412 patients (17.1%) in the nonoperative group underwent PT (*P* \< .001). However, in 2015, a total of 775 patients (7.8%) in the repair group and 12,082 patients (13.5%) in the nonoperative group were prescribed PT (*P* \< .001) ([Table 5](#table5-2325967119845912){ref-type="table"}). In 2015, patients were less likely to undergo PT before rotator cuff repair in comparison with 2010 (OR, 0.6; *P* \< .001).

###### 

Distribution of Nonoperative Treatment Modalities*^a^*
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                             2010          2015                          
  -------------------------- ------------- --------------- ------------- ---------------
  Physical therapy           679 (12.1)    9412 (17.1)     775 (7.8)     12,082 (13.5)
  Corticosteroid injection   1340 (23.9)   16,573 (30.1)   1631 (16.5)   28,332 (31.7)
  NSAIDs                     299 (5.3)     4341 (7.9)      509 (5.2)     8653 (9.7)

*^a^*Data are reported as n (%). NSAID, nonsteroidal anti-inflammatory drug.

Corticosteroid Injections {#section5-2325967119845912}
-------------------------

In 2010, a total of 1340 patients (23.9%) in the repair group and 16,573 patients (30.1%) in the nonoperative group received a corticosteroid injection (*P* \< .001). In 2015, a total of 1631 patients (16.5%) in the repair group and 28,332 patients (31.7%) in the nonoperative group were administered a corticosteroid injection (*P* \< .001) ([Table 5](#table5-2325967119845912){ref-type="table"}). Compared with 2010, patients were less likely to receive a corticosteroid injection before rotator cuff repair as part of their care (OR, 0.6; *P* \< .001).

Nonsteroidal Anti-inflammatory Drugs {#section6-2325967119845912}
------------------------------------

In 2010, a total of 299 patients (5.3%) in the repair group and 4341 patients (7.9%) in the nonoperative group were prescribed an NSAID (*P* = .2). However, in 2015, a total of 509 patients (5.2%) in the repair group and 8653 patients (9.7%) in the nonoperative group were prescribed an NSAID (*P* \< .001) ([Table 5](#table5-2325967119845912){ref-type="table"}). There was no difference in being prescribed an NSAID before rotator cuff repair in 2015 versus 2010 (OR, 1.0; *P* = .6).

Operative Management {#section7-2325967119845912}
--------------------

Before operative management, magnetic resonance imaging was more likely to be ordered in 2015 than in 2010 (78.8% vs 75.9%, respectively; OR, 1.2; *P* \< .001). In 2010, there were 4305 cases (76.9%) of rotator cuff repair with concomitant acromioplasty, while the proportion of concomitant acromioplasty decreased in 2015 (4762 cases, 48.2%; OR, 0.4; *P* \< .001). The distribution of concomitant procedures is provided in [Table 6](#table6-2325967119845912){ref-type="table"}. Additionally, there was a slight difference in the rate of concomitant biceps tenodesis in 2015 and 2010 (14.8% vs 14.6%, respectively; OR, 1.1; *P* = .01).

###### 

Distribution of Concomitant Procedures*^a^*
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                     2010          2015
  ------------------ ------------- -------------
  Acromioplasty      4305 (76.9)   4762 (48.2)
  Biceps tenodesis   815 (14.6)    1465 (14.8)

*^a^*Data are reported as n (%).

Discussion {#section8-2325967119845912}
==========

In this investigation, we established that the operative treatment of full-thickness rotator cuff tears is slightly increasing and that patients are less likely to undergo conservative management as an initial treatment modality. Although these data suggest that physicians are treating rotator cuff tears more aggressively, concomitant procedures are being performed more selectively. During rotator cuff repair, performing concomitant acromioplasty is decreasing, while the trend of concomitant biceps tenodesis slightly increased. Although a causal relationship was unable to be established in this investigation, the CPGs developed by the AAOS as well as the publication of prospective investigations have improved our understanding of the treatment, outcomes, and natural history of rotator cuff injuries, which has factored significantly into changes in patient management.

The results of our investigation suggest that the majority of patients are not undergoing conservative management at the time of initial presentation of a rotator cuff tear. Although based on the best available evidence at the time of conception, the CPGs were met with skepticism. Opponents of the CPGs believed that guidelines must be based on adequate evidence to dictate standards of practice; however, higher level investigations did not exist at that time.^[@bibr23-2325967119845912]^ Since the publication of the CPGs, several randomized clinical trials published from 2010 to 2015 have directly compared clinical outcomes in patients undergoing rotator cuff repair and those undergoing conservative management.^[@bibr18-2325967119845912],[@bibr19-2325967119845912],[@bibr31-2325967119845912],[@bibr32-2325967119845912]^ Although Kukkonen et al^[@bibr18-2325967119845912]^ and Lambers Heerspink et al^[@bibr19-2325967119845912]^ demonstrated equivalent outcomes at short-term follow-up, Moosmayer et al^[@bibr31-2325967119845912]^ demonstrated that patients treated with rotator cuff repair had better outcomes that reached clinical significance than those treated conservatively by 1 year postoperatively. However, operative management only offered moderate improvement that did not reach the minimal clinically important difference by 5 years postoperatively.^[@bibr32-2325967119845912],[@bibr36-2325967119845912]^ The CPGs offered inconclusive recommendations regarding the conservative management of full-thickness rotator cuff tears. Despite the technical difficulties associated with tear progression after nonoperative care, it is important to note that there is high-level evidence that suggests that conservative and operative management yield equivalent outcomes.^[@bibr19-2325967119845912],[@bibr32-2325967119845912]^ Therefore, surgeons must consider additional factors when discussing clinical management. For example, young, active patients may have higher functional demands that may limit the efficacy of conservative treatment. Additional patient factors including insurance status, age, obesity, or status of medical optimization may influence clinical decision making. It is imperative that physicians offer treatment options that best fit the needs of their patients, irrespective of the inconclusive recommendations by the CPGs.

Moosmayer et al^[@bibr31-2325967119845912]^ found that, despite no difference in functional outcomes at final follow-up, 37% of patients who were treated nonoperatively had worsening tear progression at final follow-up, which was also associated with inferior outcomes. Patients may elect for nonoperative management, or insurers may require initial conservative management; however, these treatment options may not be efficacious and may ultimately require further surgical intervention. Approximately half of patients treated conservatively for full-thickness rotator cuff tears are reported to experience a clinically significant increase in tear size, which may eventually be unresponsive to nonoperative treatment.^[@bibr40-2325967119845912]^ Subsequent increases in tear size may reduce the likelihood of successful rotator cuff repair.^[@bibr10-2325967119845912]^ Therefore, primary surgical repair may be viewed as a more definitive treatment option in patients with full-thickness tears^[@bibr15-2325967119845912]^ and may also prevent further tear progression or further degeneration of the tissue.^[@bibr10-2325967119845912]^

Another consideration for performing rotator cuff repair is the economic and societal values of operative versus nonoperative management for full-thickness rotator cuff tears. Operative management has been shown to yield a societal savings of US\$13,771 over a patient's lifetime, ranging from US\$77,662 for patients aged 30-39 years to US\$11,997 for patients aged 70-79 years.^[@bibr27-2325967119845912]^ Furthermore, on an annual basis, rotator cuff repair for full-thickness tears yields an estimated US\$3.44 billion in societal savings.^[@bibr27-2325967119845912]^ Rotator cuff tears represent a substantial economic burden to society, and rotator cuff repair may be the most efficacious treatment to improve clinical outcomes and reduce the cost burden. Furthermore, it is imperative for patients who are employed at the time of surgery to return to work. The motivation to return to work is multifactorial, as it is influenced by economic need, disability coverage, social situation, comorbid conditions, and health care and benefits. However, patients may be counseled that 89% of those with workers' compensation status were able to return to work at maximal medical improvement by 7.6 months postoperatively after rotator cuff repair.^[@bibr6-2325967119845912]^ Additionally, the nonoperative management of rotator cuff tears may lead to tear progression.^[@bibr40-2325967119845912]^ Arthroscopic rotator cuff repair and reverse total shoulder arthroplasty are more cost-effective treatment modalities in comparison with nonoperative management. Although arthroscopic rotator cuff repair may have a high rate of retears for large-to-massive rotator cuff tears, it offers a more cost-effective treatment modality with slightly improved clinical outcomes in comparison with reverse total shoulder arthroplasty.^[@bibr24-2325967119845912]^ As health care shifts toward more efficient care,^[@bibr7-2325967119845912]^ physicians may focus on treatment modalities that minimize costs while simultaneously improving clinical outcomes.

Concomitant acromioplasty has been commonly performed with rotator cuff repair, as it offers several theoretical advantages by increasing the subacromial space to facilitate repair and relieve compression on the repaired construct.^[@bibr34-2325967119845912]^ However, there is mounting evidence to suggest that concomitant acromioplasty does not offer any added clinical benefit in comparison with rotator cuff repair without acromioplasty.^[@bibr1-2325967119845912],[@bibr25-2325967119845912],[@bibr26-2325967119845912],[@bibr39-2325967119845912],[@bibr41-2325967119845912]^ Performing acromioplasty reduces the critical shoulder angle to a favorable range of 30° to 35°, which decreases contact between the acromion and rotator cuff.^[@bibr14-2325967119845912]^ The CPGs published by the AAOS offer moderate strength of recommendation that routine acromioplasty should not be performed at the time of rotator cuff repair.^[@bibr2-2325967119845912],[@bibr23-2325967119845912],[@bibr35-2325967119845912]^ The results of this investigation suggest that significantly fewer physicians are performing concomitant acromioplasty in patients with full-thickness rotator cuff tears. Therefore, it is possible that physicians are selectively performing acromioplasty in patients with certain anatomic variations instead of performing this adjuvant procedure in all patients. Additionally, the proportion of patients who underwent biceps tenodesis has slightly increased. Because the long head of the biceps tendon is a potential pain generator, surgeons may elect to perform biceps tenodesis as a concomitant procedure to rotator cuff repair to eliminate a source of pain and to reduce the risk of returning to the operating room for a separate biceps tenodesis procedure. However, the threshold for identifying biceps tendinopathy may not have changed and may contribute to the trends observed in this investigation. As further investigations are conducted regarding the clinical outcomes and histopathology of biceps tendinopathy, indications for biceps tenodesis may be more clearly defined.

Although the Humana database provides a large sample size that allows for the evaluation of overall national trends in clinical practice, the use of this database has inherent limitations. Because of the retrospective nature of this study, we were unable to standardize clinical indications, operative techniques, or rehabilitation protocols, which may have affected the overall results of our investigation. Additionally, the results of this investigation are dependent on accurate coding within the database. While this database contained data for more than 20 million patients, it is not representative of the entire population. Patient factors such as age, diabetes mellitus, smoking status, and osteoporosis have been shown to affect clinical outcomes after rotator cuff repair.^[@bibr16-2325967119845912]^ The effects of these factors on the management of rotator cuff tears could not be assessed in this study. Additional factors such as fatty infiltration, tear size, tear location, involved tendon, and muscle atrophy could also not be assessed in this investigation. Furthermore, it was unclear if the diagnosis of a rotator cuff tear was based on clinical findings or magnetic resonance imaging. Additionally, NSAIDs are readily available over the counter and do not require a prescription; therefore, the incidence of NSAID usage may have been underreported. The incidence of concomitant biceps tendon release was unable to be assessed because this procedure does not have a specific CPT code. Some surgeons prefer to perform this procedure instead of biceps tenodesis, and changes in management may have occurred over the duration of the study period. Last, laterality could not be accurately identified in this investigation. Thus, it is possible that patients included in this investigation underwent conservative management for rotator cuff dysfunction on the contralateral side.

Conclusion {#section9-2325967119845912}
==========

From 2010 to 2015, there were changes in the management of full-thickness rotator cuff tears, including decreased preoperative utilization of corticosteroid injections and PT as well as a decrease in concomitant acromioplasty, and the rate of biceps tenodesis slightly increased. As CPGs and prospective investigations continue to proliferate, management practices of patients with full-thickness rotator cuff tears continue to evolve.
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